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Background: Exercise therapy maximizes cardiopulmonary reserve and functional status in patients with heart failure (HF). However, exercise 
increases heart rate and adrenergic tone and may be proarrhythmic. Few data are available regarding the safety of exercise training in patients with 
implantable cardioverter defibrillators (ICDs).
Methods: Heart Failure: A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION) enrolled 2331 outpatients with HF and an 
ejection fraction less than or equal to 35%. In order to assess the safety of exercise in ICD patients, Cox proportional hazards modeling was used to 
examine the relation between exercise training and ICD shocks.
Results: We identified 1053 patients (45%) in HF-ACTION with an ICD at baseline. At enrollment, ICD patients randomized to exercise training 
(n=546) and usual care (n=507) were comparable in terms of their clinical characteristics (p>0.1 for all). The median age was 61, 21% were female, 
and 61% had ischemic cardiomyopathy. Median peak VO2 was 14.1 ml/kg/min and the median QRS duration was 120 msec. Forty-one percent 
of the ICD patients also received biventricular pacing. In terms of medical therapy, 94% received beta-blockers, 93% received ace-inhibitors or 
angiotensin receptor blockers, and 26% received a membrane active antiarrhythmic drug. Over median 2.2 years of follow-up, 20% (108) of the 
exercise patients had a shock, compared to 22% (113) of the control patients. After adjustment for prognostically important clinical variables, 
both a history of sustained VT/VF (HR 1.85 [1.41-2.42], p<0.001) and a history of AF/AFL (HR 1.53 [1.16-2.03], p=0.0029) were associated with 
an increased risk of ICD shocks. Additionally, there was a trend toward increased ICD shocks with digoxin pharmacotherapy (HR 1.31 [1.00-1.71], 
p=0.053). Exercise training was not associated with the occurrence of ICD shocks (HR 0.94 [0.72-1.23], p=0.66).
Conclusion: We found no evidence of increased ICD shocks in patients with HF and reduced LV function who underwent aggressive exercise 
training. Exercise therapy should not be prohibited in ICD recipients with HF for fear of inducing ventricular dysrhythmias requiring ICD firing.
